Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Lung Ultrasound in Pleuritic Chest Pain

Conditions:   Community Acquired Pneumonia;   Pleuritis;   Pulmonary Embolism;   Lung Cancer
Intervention:   Procedure: Lung ultrasound
Sponsor:   University of Milan
Recruiting - verified April 2014

Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery

Conditions:   Cardiac Death;   Congestive Heart Failure;   Angina Pectoris;   Stroke;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:  
Sponsor:   Technische Universität München
Recruiting - verified April 2014

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

High Intensity Physiotherapy for Hip Fractures

Condition:   Hip Fractures
Interventions:   Other: Intensive physiotherapy;   Other: Usual Care
Sponsor:   The Alfred
Recruiting - verified April 2014

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified April 2014

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Not yet recruiting - verified April 2014

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
Sponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
Recruiting - verified April 2014

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Conditions:   Fetal Demise;   Fetal Growth Restriction;   Preeclampsia;   Abruptio Placentae;   Thromboembolism
Intervention:   Drug: enoxaparin
Sponsor:   HaEmek Medical Center, Israel
Recruiting - verified March 2013

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Conditions:   Venous Thromboembolism;   Pulmonary Embolism
Intervention:   Drug: dalteparin injection
Sponsors:   University of Rochester;   National Heart, Lung, and Blood Institute (NHLBI);   Eisai Inc.
Active, not recruiting - verified April 2014

Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery

Conditions:   Arthroplasty, Replacement;   Thromboembolism
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Conditions:   Arterial Thromboembolic Events;   Atrial Fibrillation
Interventions:   Drug: Placebo;   Drug: Dalteparin
Sponsors:   Duke University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2014

Tranexamic Acid in Urologic Surgery

Conditions:   Bleeding;   Prostatectomy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Università Vita-Salute San Raffaele
Completed - verified July 2010

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Conditions:   Deep Vein Thrombosis of Lower Limb;   Pulmonary Embolism (PE);   Bleeding
Interventions:   Device: ActiveCare CECT device;   Drug: Enoxaparin
Sponsor:   Medical Compression Systems
Completed - verified February 2010

Nurses' Health Study (Cardiovascular Component)

Conditions:   Cardiovascular Diseases;   Diabetes Mellitus;   Coronary Disease;   Heart Diseases;   Cerebrovascular Accident;   Pulmonary Embolism;   Angina Pectoris;   Myocardial Infarction;   Menopause;   Postmenopause
Intervention:  
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2014

Get CardioSmart

You're Invited